Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DLG2 antisense RNA 1 (DLG2-AS1) is a non-coding RNA gene identified in the Ensembl database under accession ENSG00000274006. It is annotated as a miscellaneous RNA, functioning as an antisense transcript to the DLG2 gene. There is currently no evidence that DLG2-AS1 encodes a protein or is involved in canonical biological pathways as a receptor, enzyme, transporter, or transcription factor. Its function remains unclear, and it is not regarded as a recognized therapeutic target in drug development or disease biology.
Not applicable; DLG2-AS1 does not encode a protein and is not known to be directly involved in mechanisms targeted by drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DLG2 antisense RNA 1 (DLG2-AS1).